Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by lscfaon May 04, 2021 10:13am
200 Views
Post# 33122773

RE:RE:RE:RE:Phantom menace strikes again

RE:RE:RE:RE:Phantom menace strikes againI partially blame the co for the volatile stock price because they report unnecessarily volatile financial numbers.   


beancounter11 wrote: There is no formal definition of adjusted ebitda, generally this is set by the company.  I don't use Ebitda in my analysis, however your point is importnant because alot of lazy analysts don't spend much time crunching the numbers and just use the ones provided by the company.  A good analyst will crunch the numbers and often use their own definition to be consistent from company to company.

lscfa wrote:

Co. removed swings in unrealized warrant liabilities from adj. ebitda calc (See image).     It should do the same for unrealized changes in fair value of phantom stock plan liability.    
 

       
 

lscfa wrote:

 

I believe the answer is it is buried in the line item called:     net change in working capital, decrease to accrued liabilities

This understates the cash flow from operations no. and by not adding it back to adjusted ebitda that no is understated too.

In the June 2020 qtr a $3.6 million Covid grant was not subtracted from the adj. ebitda calc., overstating it and making comp with the upcoming Jun 2021 qtr look worse than it really is.

These bozos need to try harder at calculating adj ebitda so that it reflects economic reality and provides a better picture of what can be expected going forward under normalized conditions. 



 

lscfa wrote:

 

Any forensic accountants out there?


Included in SG&A this qtr is $2.465 million of phantom stock expense but no cash was paid out. It was all due to a change in the fair value of the plan. Why does this non-cash item not appear as an add back on the cash flow statement? Why isn’t this non-cash item included in the calc. for adjusted ebitda like other stock compensation is?
 

 

Qtr ending

SG&A

Phantom exp

adj ebitda (reported)

Mar 21

14,509

2,465

5,468

Dec 20

12,274

185

9,458

Sept 20

13,550

459

7,720

Jun 20

16,428

4,308

16,287

Mar 20

10,577

(697)

7,869

Dec19

10,174

428

5,569

Sep19

10,231

1,054

4,883

 

 


 

 




<< Previous
Bullboard Posts
Next >>